ERBB2 and breast neoplasm: On immunofluorescence (IF), we observed strong binding of KSP*-IR800 to the surface (arrow) of BT474 (ErbB2+) cells in the human xenograft breast tumor sections, Fig. S7A, and minimal signal with PPS*-IR800, Fig. S7B.